ALK-IN-23 是一种有效的 ALK 抑制剂,对 ALKWT、ALKL1196M 和 ALKG1202R 的 IC50 分别为 1.6 nM、0.71 nM 和 1.3 nM,可将细胞阻滞在 G2 期并诱导细胞凋亡 (apoptosis),在体外抑制癌细胞迁移和集落形成,并在 H2228 异种移植裸鼠模型中表现出良好的抗肿瘤活性与低毒性。
产品编号: MS-W10699 CAS No.: 3033549-18-4 分子式: C26H29ClN8O3S 分子量: 569.08
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

ALK-IN-23 是一种有效的 ALK 抑制剂,对 ALKWT、ALKL1196M 和 ALKG1202R 的 IC50 分别为 1.6 nM、0.71 nM 和 1.3 nM,可将细胞阻滞在 G2 期并诱导细胞凋亡 (apoptosis),在体外抑制癌细胞迁移和集落形成,并在 H2228 异种移植裸鼠模型中表现出良好的抗肿瘤活性与低毒性。

生物实验数据

生物活性 ALK-IN-23 is a potent ALK inhibitor with IC50 values of 1.6 nM, 0.71 nM, and 1.3 nM against ALKWT, ALKL1196M, and ALKG1202R, respectively, that induces G2 phase cell cycle arrest and apoptosis, inhibits cancer cell migration and colony formation in vitro, and exhibits favorable antitumor activity with low toxicity in the H2228 xenograft nude mouse model.
IC50 & Target

IC50: 1.6 nM (ALKWT), 0.71 nM (ALKL1196M), 1.3 nM (ALKG1202R)

体外研究
(In Vitro)

ALK-IN-23 (compound Y28) (0-5 μM; 72h) has highly inhibitory activity against H3122, H2228, Karpas299 and A549.
ALK-IN-23 (25-100 nM; 3 days) clearly reduces the number of H2228 cell colonies, and almost completely abolishes the formation of colonies at 100 nM.
ALK-IN-23 (100-200 nM; 48 h) facilitates the apoptosis of H2228 cells.
ALK-IN-23 (5-10 nM; 24 and 48 h) is effective to block the migration of most cells at a dose of 10 nM.
ALK-IN-23 (25-100 nM; overnight) significantly increases the percentage of cells in the G2 phase.

Cell Proliferation Assay

Cell Line: H3122, H2228, Karpas299 and A549
Concentration: 0-5 μM
Incubation Time: 72 h
Result: Exhibited highly inhibitory activity against H3122, H2228, Karpas299 and A549 with IC50s of 12 nM, 17 nM, 15 nM and 1.33 μM.

Apoptosis Analysis

Cell Line: H2228 cells
Concentration: 100 nM, 200 nM
Incubation Time: 48 h
Result: Facilitated the apoptosis of H2228 cells in a dose dependent manner and exhibited a more pro-apoptotic effect than that of Ceritinib (MS-J67370).

Cell Migration Assay

Cell Line: H2228 cells
Concentration: 5 nM and 10 nM
Incubation Time: 24 and 48 h
Result: Blocked the migration of most cells at a dose of 10 nM (migration rate: 24 h 2.31%, 48 h: 5.01%).

Cell Cycle Analysis

Cell Line: H2228 cells
Concentration: 25 nM, 50 nM, 100 nM
Incubation Time: Overnight
Result: Significantly increased the percentage of cells in the G2 phase from 11.28% to 73.23% in a dramatic dose-dependent manner, accompanied by a resultant loss of G1-and S-phase populations.
体内研究
(In Vivo)

ALK-IN-23 notes a moderate half-life of 16.3 min and a high intrinsic liver clearance of 152.9 mL/min/kg in rats.
ALK-IN-23 (25 and 50 mg/kg; IG; once every 2 days; for 14 days) exhibited gentle antitumor efficacy and no significant weight loss in H2228 xenograft mice model.

Animal Model: Female BALB/c nude mice (5×106 cells H2228 cells suspended in serum-free media were injected into the flanks)
Dosage: 25 and 50 mg/kg
Administration: IG; once every 2 days; for 14 days
Result: Presented moderate antitumor efficacy with the tumor growth inhibition (TGI) of 70.46% at 50 mg/kg.
Possessed gentle antitumor efficacy and exhibited no significant weight loss.

化学信息

分子量 569.08
分子式 C26H29ClN8O3S
CAS No. 3033549-18-4

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础